Australian Clinical Labs Limited
Research Australian Clinical Labs Limited (ACL.AX) on Bullrun: market cap AUD 533.44M, P/E 23.8, dividend yield 4.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerACL.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyAUD
- Market capAUD 533.44M
- P/E23.8
- Dividend yield4.5%
- Financial periodFY2025
- RevenueAUD 736.15M
- Revenue growth6.7%
- Net incomeAUD 32.43M
- Free cash flowAUD 174.39M
- Gross margin82.6%
Valuation Snapshot
latest market cap is AUD 533.44M; P/E is 23.8; dividend yield is 4.5%.
Peer valuation comparison
Latest P/E is 23.83x versus a Healthcare sector median of 24.73x (3.6% below).
Latest dividend yield is 4.51% versus a Healthcare sector median of 1.81% (149.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 736.15M | AUD 32.43M | AUD 174.39M | 82.6% | 0.17 | AUD 21.44M | AUD 290.38M | AUD 171.35M |
| FY2024 | AUD 689.73M | AUD 23.93M | AUD 153.09M | 82.7% | 0.12 | AUD 26.14M | AUD 308.90M | AUD 177.53M |
| FY2023 | AUD 692.10M | AUD 35.90M | AUD 136.75M | 81.8% | 0.18 | AUD 19.96M | AUD 316.32M | AUD 172.42M |
| FY2022 | AUD 989.30M | AUD 178.24M | AUD 262.84M | 79.0% | 0.88 | AUD 26.37M | AUD 262.38M | AUD 232.44M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | AUD 533.44M | 23.8 | 4.6% | 0.13 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.13 AUD, yield 4.5%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.13 AUD |
| FY2024 | 0.12 AUD |
| FY2023 | 0.14 AUD |
| FY2022 | 0.53 AUD |
About Australian Clinical Labs Limited
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers cardiac testing, gastroenterology, haematology, chemical pathology, antenatal testing, serology and microbiology, cervical screening, commercial drug and alcohol testing, STI Testing, veterinary pathology, molecular cancer services, clinical trials pathology, advanced genetic testing, functional pathology, histopathology and cytopathology, CPD education programs for clinicians, and allergy and immunology...
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Australian Clinical Labs Limited's market cap?
Australian Clinical Labs Limited's market capitalization is AUD 533.44M.
What is Australian Clinical Labs Limited's P/E ratio?
Australian Clinical Labs Limited's price-to-earnings (P/E) ratio is 23.8.
Does Australian Clinical Labs Limited pay a dividend?
Australian Clinical Labs Limited has a dividend yield of 4.5%.
What does Australian Clinical Labs Limited do?
Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers cardiac testing, gastroenterology, haematology, chemical pathology, antenatal testing, serology and microbiology, cervical screening, commercial drug and alcohol testing, STI Testing, veterinary pathology, molecular cancer services, clinical trials pathology, advanced genetic testing, functional pathology, histopathology and cytopathology, CPD education programs for clinicians, and allergy and immunology services.